Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0XT0W
|
||||
Former ID |
DIB014926
|
||||
Drug Name |
Debio 1347
|
||||
Indication | Late-stage solid tumors [ICD9: 140-199, 210-229; ICD10:C00-C75, C7A, C7B, D10-D36, D3A] | Phase 1 | [1] | ||
Company |
Debiopharm
|
||||
Structure |
![]() |
Download2D MOL |
|||
Target and Pathway | |||||
Target(s) | Fibroblast growth factor receptor | Target Info | Modulator | [2] | |
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800037338) | ||||
REF 2 | The fibroblast growth factor receptor genetic status as a potential predictor of the sensitivity to CH5183284/Debio 1347, a novel selective FGFR inhibitor. Mol Cancer Ther. 2014 Nov;13(11):2547-58. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.